Related Experiment Videos
A new CARD15 mutation in Blau syndrome
Marjan M van Duist1, Mario Albrecht, Marta Podswiadek
1Department of Clinical and Biological Sciences, Division of Medical Genetics, University of Torino, Orbassano, Italy.
European Journal of Human Genetics : EJHG
|April 7, 2005
Summary
Researchers identified a new mutation (E383K) in the CARD15/NOD2 gene causing Blau syndrome, a rare inflammatory disease. This finding advances understanding of innate immunity pathways and genetic susceptibility to inflammatory disorders.
Area of Science:
- Genetics
- Immunology
- Molecular Biology
Background:
- The CARD15/NOD2 gene encodes a cellular receptor crucial for innate immunity via the NF-kappaB pathway.
- CARD15/NOD2 is a key susceptibility gene for Crohn's disease (CD) and the causative gene for Blau syndrome (BS).
- CD-associated variants decrease NF-kappaB activation, while BS mutations increase it.
Purpose of the Study:
- To identify the genetic basis of Blau syndrome in an Italian family.
- To characterize the functional impact of a novel CARD15/NOD2 mutation on NF-kappaB signaling.
- To explore the role of the NACHT domain in autoinflammatory diseases.
Main Methods:
- Genetic analysis of an Italian family with Blau syndrome.
- Mutation detection and pathogenicity assessment (cosegregation, control analysis).
- Analysis of protein domain conservation and structural role.
Main Results:
- A novel mutation, E383K, was identified in the CARD15/NOD2 gene of the affected family.
- The E383K mutation cosegregated with Blau syndrome in the family and was absent in controls.
- The mutation affects a conserved glutamate residue near the Walker B motif in the NACHT domain, crucial for nucleotide binding.
Conclusions:
- The E383K mutation in CARD15/NOD2 is pathogenic and causes Blau syndrome.
- This finding highlights the critical role of the NACHT domain in regulating NF-kappaB activation and innate immunity.
- Mutations in NACHT domain-containing proteins can lead to autoinflammatory phenotypes.